The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities
Open accessAbstract
The rhesus macaque tripartite motif containing protein TRIM5α specifically restricts HIV-1 infection at an early post-entry step before reverse transcription [Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. & Sodroski, J. (2004) Nature 427, 848–853]. Here, we show that the human and African green monkey (AGM) TRIM5α genes encode Ref1 and Lv1 antiretroviral activities, respectively. Expression of TRIM5α in permissive cat cells renders them resistant to restriction-sensitive murine leukemia virus but not closely related insensitive virus. Disruption of TRIM5α expression in human and AGM cells with small interfering RNA rescues infectivity of restricted virus without affecting unrestricted virus. We also demonstrate that the activity of the murine restriction factor Fv1 depends on TRIM5α expression when Fv1 is expressed in human cells. Furthermore, a drug that modifies the behavior of the related promyelocytic leukemia protein PML specifically rescues infection by viruses restricted by human TRIM5α. Alignment of the TRIM5α proteins from rhesus macaque and AGM indicates an 18-aa insertion. We speculate that this insertion may contribute to the broader specificity of the AGM TRIM5α restriction as compared with the human and rhesus macaque proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
Hypermutation of HIV-1 DNA in the Absence of the Vif Protein
Lecossier, D., Bouchonnet, F., Clavel, F., & Hance, A. J. (2003) · Science · doi:10.1126/science.1083338 · Cited by 651
Lazo, G., Kantarjian, H., Estey, E., Thomas, D., O'Brien, S., & Cortes, J. (2003) · Cancer · doi:10.1002/cncr.11314 · Cited by 494
Positional cloning of the mouse retrovirus restriction gene Fvl
Best, S., Tissier, P. L., Towers, G., & Stoye, J. P. (1996) · Nature · doi:10.1038/382826a0 · Cited by 493
Self-citationStructural insights into ligand interactions at the acetylcholinesterase peripheral anionic site
Bourne, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg005 · Cited by 488
Zhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., & de Thé, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3978 · Cited by 427
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
Towers, G. J., Hatziioannou, T., Cowan, S., Goff, S. P., Luban, J., & Bieniasz, P. D. (2003) · Nature Medicine · doi:10.1038/nm910 · Cited by 377
Self-citationHow acute promyelocytic leukaemia revived arsenic
Zhu, J., Chen, Z., Lallemand-Breitenbach, V., & de Thé, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc887 · Cited by 321
Schröfelbauer, B., Chen, D., & Landau, N. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307132101 · Cited by 311
Restriction of lentivirus in monkeys
Besnier, C., Takeuchi, Y., & Towers, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172384599 · Cited by 279
Self-citationCellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
Cowan, S., Hatziioannou, T., Cunningham, T., Muesing, M. A., Gottlinger, H. G., & Bieniasz, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162299499 · Cited by 275
Species-Specific, Postentry Barriers to Primate Immunodeficiency Virus Infection
Hofmann, W., Schubert, D., LaBonte, J., Munson, L., Gibson, S., Scammell, J., Ferrigno, P., & Sodroski, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10020-10028.1999 · Cited by 250
A conserved mechanism of retrovirus restriction in mammals
Towers, G., Bock, M., Martin, S., Takeuchi, Y., Stoye, J. P., & Danos, O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200286297 · Cited by 246
Self-citationA dominant block to HIV-1 replication at reverse transcription in simian cells
Münk, C., Brandt, S. M., Lucero, G., & Landau, N. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212400099 · Cited by 231
Restriction of multiple divergent retroviruses by Lv1 and Ref1
Hatziioannou, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg042 · Cited by 229
Cytoplasmic Recruitment of INI1 and PML on Incoming HIV Preintegration Complexes
Turelli, P., Doucas, V., Craig, E., Mangeat, B., Klages, N., Evans, R., Kalpana, G., & Trono, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00255-6 · Cited by 224
Role of ICP0 in the Strategy of Conquest of the Host Cell by Herpes Simplex Virus 1
Hagglund, R., & Roizman, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2169-2178.2004 · Cited by 219
A MAJOR GENETIC LOCUS AFFECTING RESISTANCE TO INFECTION WITH MURINE LEUKEMIA VIRUSES
Pincus, T., Rowe, W. P., & Lilly, F. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.6.1234 · Cited by 217
B ALANCED P OLYMORPHISM S ELECTED BY G ENETIC V ERSUS I NFECTIOUS H UMAN D ISEASE
Dean, M., Carrington, M., & O'Brien, S. J. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103149 · Cited by 167
Kozak, C. A., & Chakraborti, A. (1996) · Virology · doi:10.1006/viro.1996.0604 · Cited by 160
Use of a Transient Assay for Studying the Genetic Determinants of Fv1 Restriction
Bock, M., Bishop, K. N., Towers, G. J., & Stoye, J. P. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7422-7430.2000 · Cited by 131
Self-citationJolicoeur, P., & Rassart, É. (1980) · Journal of Virology · doi:10.1128/jvi.33.1.183-195.1980 · Cited by 125
Fraile‐Ramos, A., Kohout, T. A., Waldhoer, M., & Marsh, M. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00079.x · Cited by 118
Restriction factors: a defense against retroviral infection
Bieniasz, P. D. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00123-9 · Cited by 112
Gene transduction efficiency in cells of different species by HIV and EIAV vectors
Ikeda, Y., Collins, M. K., Radcliffe, P. A., Mitrophanous, K., & Takeuchi, Y. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301708 · Cited by 84
Goff, S. P. (2003) · Cell · doi:10.1016/s0092-8674(03)00602-0 · Cited by 77
As 2 O 3 Enhances Retroviral Reverse Transcription and Counteracts Ref1 Antiviral Activity
Berthoux, L., Towers, G. J., Gurer, C., Salomoni, P., Pandolfi, P. P., & Luban, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.3167-3180.2003 · Cited by 73
Self-citationProtein fold analysis of the B30.2-like domain
Seto, M. H., Liu, H.-L. C., Zajchowski, D. A., & Whitlow, M. D. (1999) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19990501)35:2<235::aid-prot9>3.0.co;2-x · Cited by 57
Immunologic Profile of Highly Exposed Yet HIV Type 1-Seronegative Men
Yang, O. O., Boscardin, W. J., Matud, J. L., Hausner, M. A., Hultin, L. E., Hultin, P. M., Shih, R., Ferbas, J., Siegal, F. P., Shodell, M., et al. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/08892220260235416 · Cited by 38
Jung, Y. T., & Kozak, C. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5385-5387.2000 · Cited by 28
Characterizationof Murine Leukemia Virus Restriction inMammals
Besnier, C., Ylinen, L., Strange, B., Lister, A., Takeuchi, Y., Goff, S., & Towers, G. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.13403-13406.2003 · Cited by 21
Self-citation
Cited by
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
TRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., & Sodroski, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509996103 · Cited by 739
Sawyer, S. L., Wu, L. I., Emerman, M., & Malik, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409853102 · Cited by 688
HIV Restriction Factors and Mechanisms of Evasion
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 487
Metadata
- Authors
- Keckesova, Z., Ylinen, L. M. J., & Towers, G. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10780-10785
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2051777873
- Cited by
- 344
- References
- 37
- FWCI
- 12.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.